Person
Ono, Fumihito
|
|
Biography and Research Interest
1991 M.D., Faculty of Medicine, University of Tokyo
1991 Resident, Internal Medicine, National Medical Center Hospital, Tokyo, Japan
1996 Ph.D., Faculty of Medicine, University of Tokyo
1996 Postdoctoral Fellow, the Japan Society for the Promotion of Science, Tsukuba, Japan
1998 Postdoctoral Fellow, SUNY at Stony Brook
2000 Research Assistant Professor, SUNY at Stony Brook
2003 Assistant Professor, the Whitney Laboratory for Marine Bioscience & Department of Neuroscience, University of Florida
2007 Chief, Section on Model Synaptic Systems, Laboratory of Molecular Physiology, NIAAA/NIH
2014 Professor&Chair, Department of Physiology, Osaka Medical College
2021 School name changed to Osaka Medical and Pharmaceutical University
1991 Resident, Internal Medicine, National Medical Center Hospital, Tokyo, Japan
1996 Ph.D., Faculty of Medicine, University of Tokyo
1996 Postdoctoral Fellow, the Japan Society for the Promotion of Science, Tsukuba, Japan
1998 Postdoctoral Fellow, SUNY at Stony Brook
2000 Research Assistant Professor, SUNY at Stony Brook
2003 Assistant Professor, the Whitney Laboratory for Marine Bioscience & Department of Neuroscience, University of Florida
2007 Chief, Section on Model Synaptic Systems, Laboratory of Molecular Physiology, NIAAA/NIH
2014 Professor&Chair, Department of Physiology, Osaka Medical College
2021 School name changed to Osaka Medical and Pharmaceutical University
Non-Zebrafish Publications
Sasaki M., Nakahara.M., Hashiguchi, T., Ono, F. Plasma membrane potential modulates ERK activity (2024) eLife https://doi.org/10.7554/eLife.101613.1
Kazumasa Komura, Kazuki Nishimura, Kiyoshi Takahara, Mitsuaki ishida, Kensuke Hirosuna, Ryoichi Maenosono, Masahiko Ajiro, Kengo Iwatsuki, Yuki Nakajima, Takuya Tsujino, Kohei Taniguchi, Tomohito Tanaka, Teruo Inamoto, Yoshinobu Hirose, Fumihito Ono, Yoichi Kondo, Akihide Yoshimi, Haruhito Azuma, and Moritoshi Sakamoto Mechanistic Insights into Lethal Hyper Progressive Disease Induced by PD-L1 Inhibitor in Metastatic Urothelial Carcinoma (2024) npj Precision Oncology 8, Article number: 206
Sakata, S., Ono, F., Allosteric inhibition of muscle-type nicotinic acetylcholine receptors by a neuromuscular blocking agent pancuronium (2023) PLOS One https://doi.org/10.1371/journal.pone.0292262
Yoshimi et al., The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer (2023) Molecular Cancer 22:185 https://doi.org/10.1186/s12943-023-01897-6
Komura, K., Tokushige, S., Ishida, M., Hirosuna, K., Yamazaki , S., Nishimura, K., Ajiro, M., Ohno , T., Nakamori, K., Kinoshita, S., Tsujino, T., Maenosono, R., Yoshikawa, Y., Takai, T., Tsutsumi, T., Taniguchi, K., Tanaka, T., Takahara, K., Inamoto , T., Hirose, Y., Ono, F., Shiraishi, Y., Yoshimi, A., Azuma, H., Tertiary Lymphoid Structure and Neutrophil-Lymphocyte Ratio Coordinately Predict Outcome of Pembrolizumab (2023) Cancer Science 00:1–10. DOI: 10.1111/cas.15976
Hashimoto, R., Minoshima, M., Sakata, S., Ono, F., Ishii, H., Watakabe, Y., Nemoto, T., Yanaka, S., Kato, K., Kikuchi, K. Efficient Visible/NIR Light-driven Uncaging of Hydroxylated Thiazole Orange-based Caged Compounds in Aqueous Media (2022) Chemical Science 13(25): 7462–7467. doi: 10.1039/d2sc02364d
Yamamoto, K., Kuriu, T., Matsumura, K., Nagayasu, K., Tsukusaki, Y. Miyake, N., Yamamori, H., Yasuda, Y., Fujimoto, M., Fujiwara, M., Baba, M., Kitagawa, K., Takemoto, T., Gotoda-Nishimura, N., Takada, T., Seiriki, K., Hayata-Takano, A., Ago, Y., Kida, S., Takuma, K., Ono, F., Matsumoto, N., Hashimoto, R., Hashimoto, H., Nakazawa, T. Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophrenia (2021) Translational Psychiatry 11:548 https://doi.org/10.1038/s41398-021-01676-1
Komura, K., Inamoto, T., Tsujino, T., Matsui, Y., T., Konuma, Nishimura, K., Uchimoto, T., Tsutsumi, T., Matsunaga, T., Maenosono, R., Yoshikawa, Y., Taniguchi, K., Tanaka, T., Uehara, H., Hirata, K., Hirano, H., Nomi, H., Hirose, Y., Ono, F., Azuma, H. (2021) Increased BUB1B/BUBR1 Expression Contributes to Aberrant DNA Repair Activity Leading to Resistance to DNA Damaging Agents. Oncogene https://doi.org/10.1038/s41388-021-02021-y